Tribulations and (clinical) trials in cystic fibrosis

被引：2

作者：

Cagnina, R. Elaine ^{[1
,2
]}

Sawicki, Gregory S. ^{[1
]}

机构：

[1] Boston Childrens Hosp, Div Pulm Med, Boston, MA 02115 USA

[2] Brigham & Womens Hosp, Div Pulm & Crit Care Med, 75 Francis St, Boston, MA 02115 USA

来源：

JOURNAL OF CYSTIC FIBROSIS | 2021年 / 20卷 / 02期

关键词：

CF;

D O I：

10.1016/j.jcf.2020.12.017

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：188 / 190

页数：3

共 8 条

[1] Safety and efficacy of lenabasum in a phase 2 randomized, placebo-controlled trial in adults with cystic fibrosis [J].

Chmiel, James F. ;

Flume, Patrick ;

Downey, Damian G. ;

Dozor, Allen J. ;

Colombo, Carla ;

Mazurek, Henryk ;

Sapiejka, Ewa ;

Rachel, Marta ;

Constantine, Scott ;

Conley, Brian ;

Dgetluck, Nancy ;

Dinh, Quinn ;

White, Barbara ;

Elborn, J. Stuart .

JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) :78-85

[2] Cystic fibrosis drug trial design in the era of CFTR modulators associated with substantial clinical benefit: stakeholders' consensus view [J].

De Boeck, K. ;

Lee, T. ;

Amaral, M. ;

Drevinek, P. ;

Elborn, J. S. ;

Fajac, I ;

Kerem, E. ;

Davies, J. C. .

JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (05) :688-695

[3] Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial [J].

Eber, Ernst ;

Trawinska-Bartnicka, Maria ;

Sands, Dorota ;

Bellon, Gabriel ;

Mellies, Uwe ;

Bolbas, Katalin ;

Quattrucci, Serena ;

Mazurek, Henryk ;

Widmann, Rudolf ;

Schoergenhofer, Christian ;

Jilma, Bernd ;

Ratjen, Felix .

JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) :61-67

[4] Inhalation of Moli1901 in patients with cystic fibrosis [J].

Grasemann, Hartmut ;

Stehling, Florian ;

Brunar, Helmut ;

Widmann, Rudolf ;

Laliberte, Terry W. ;

Molina, Luis ;

Doring, Gerd ;

Ratjen, Felix .

CHEST, 2007, 131 (05) :1461-1466

[5] Factors influencing clinical trial participation for adult and pediatric patients with cystic fibrosis [J].

Lee, Marissa ;

Hu, Xun Yang ;

Desai, Sameer ;

Kwong, Eugenie ;

Fu, Joey ;

Flores, Eri ;

Lazosky, Lynda ;

Wilcox, Pearce G. ;

Mcllwaine, Maggie ;

Chilvers, Mark ;

Yang, Connie ;

Rayment, Jonathan H. ;

Quon, Bradley S. .

JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (01) :57-60

[6] Building global development strategies for cf therapeutics during a transitional cftr modulator era [J].

Mayer-Hamblett, N. ;

Van Koningsbruggen-Rietschel, S. ;

Nichols, D. P. ;

VanDevanter, D. R. ;

Davies, J. C. ;

Lee, T. ;

Durmowicz, A. G. ;

Ratjen, F. ;

Konstan, M. W. ;

Pearson, K. ;

Bell, S. C. ;

Clancy, J. P. ;

Taylor-Cousar, J. L. ;

De Boeck, K. ;

Donaldson, S. H. ;

Downey, D. G. ;

Flume, P. A. ;

Drevinek, P. ;

Goss, C. H. ;

Fajac, I ;

Magaret, A. S. ;

Quon, B. S. ;

Singleton, S. M. ;

VanDalfsen, J. M. ;

Retsch-Bogart, G. Z. .

JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (05) :677-687

[7] A phase 3, randomized, double-blind, parallel-group study to evaluate tezacaftor/ivacaftor in people with cystic fibrosis heterozygous for F508del-CFTR and a gating mutation [J].

McKone, Edward F. ;

DiMango, Emily A. ;

Sutharsan, Sivagurunathan ;

Barto, Tara Lynn ;

Campbell, Daniel ;

Ahluwalia, Neil ;

Higgins, Mark ;

Owen, Caroline A. ;

Tullis, Elizabeth .

JOURNAL OF CYSTIC FIBROSIS, 2021, 20 (02) :234-242

[8] New therapies for people with CF in the CFTR modulator world [J].

Wainwright, Claire E. .

JOURNAL OF CYSTIC FIBROSIS, 2020, 19 (05) :669-670

← 1 →